Trial Profile
Switching from etelcalcetide to evocalcet in hemodialysis patients with secondary hyperparathyroidism
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 07 Sep 2018
Price :
$35
*
At a glance
- Drugs Evocalcet (Primary)
- Indications Secondary hyperparathyroidism
- Focus Therapeutic Use
- 07 Sep 2018 New trial record